Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewDihydroergotamine mesylate is a partial α-adrenergic agonist. Partial D2 dopaminergic receptor agonist. Competitive 5-HT antagonist.
Dihydroergotamine mesylate is also offered as part of the Tocriscreen FDA-Approved Drugs. Find out more about compound libraries available from Tocris.
M. Wt | 679.79 |
Formula | C33H37N5O5.CH3SO3H |
Storage | Store at RT |
Purity | ≥98% (HPLC) |
CAS Number | 6190-39-2 |
PubChem ID | 71171 |
InChI Key | ADYPXRFPBQGGAH-UMYZUSPBSA-N |
Smiles | CS(=O)(O)=O.[H][C@]4([C@@]([H])3C[C@@H]([C@@](N[C@@]5(C)C(N([C@@]([H])(CC8=CC=CC=C8)C(N7[C@]([H])6CCC7)=O)[C@@]6(O)O5)=O)=O)CN4C)CC1=CNC2=C1C3=CC=C2 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 67.97 | 100 |
The following data is based on the product molecular weight 679.79. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.47 mL | 7.36 mL | 14.71 mL |
5 mM | 0.29 mL | 1.47 mL | 2.94 mL |
10 mM | 0.15 mL | 0.74 mL | 1.47 mL |
50 mM | 0.03 mL | 0.15 mL | 0.29 mL |
References are publications that support the biological activity of the product.
de Boer et al (1991) Carotid vascular effects of ergot. and dihydroergot. in the pig: no exclusive mediation via 5-HT1-like receptors. Br.J.Pharmacol. 104 183 PMID: 1664762
Doggrell et al (1992) Further analysis of the inhibitory effects of dihydroergotamine, cyprohept. and ketanserin on the responses of the rat aorta to 5-hydroxytryptamine. J.Auton.Pharmacol. 12 223 PMID: 1512277
Lesage et al (1998) Agonistic properties of alniditan, sumatr. and dihydroergot. on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines. Br.J.Pharmacol. 123 1655 PMID: 9605573
Villalon et al (1992) Effects of S9977 and dihydroergot. in an animal experimental model for migraine. Pharmacol.Res. 25 125 PMID: 1635891
If you know of a relevant reference for Dihydroergotamine mesylate, please let us know.
Keywords: Dihydroergotamine mesylate, Dihydroergotamine mesylate supplier, 5-HT, antagonists, partial, agonists, a-adrenergic, α-adrenergic, alpha-adrenergic, dopaminergic, D2, receptors, Partial, D2-like, alpha, Non-Selective, Serotonin, 5-HT3, Receptors, 5-Hydroxytryptamine, Dopamine, α-adrenoceptors, α-adrenoceptor, alpha-adrenocep, Non-selective, Adrenergic, Alpha, 0475, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for Dihydroergotamine mesylate. Do you know of a great paper that uses Dihydroergotamine mesylate from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review Dihydroergotamine mesylate and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.